| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-11 17:31:19 UTC |
|---|
| Update Date | 2022-03-07 02:52:13 UTC |
|---|
| HMDB ID | HMDB0029592 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Triacetin |
|---|
| Description | Triacetin, also known as enzactin or e 1518, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, triacetin is considered to be a triradylglycerol. Based on a literature review a significant number of articles have been published on Triacetin. |
|---|
| Structure | CC(=O)OCC(COC(C)=O)OC(C)=O InChI=1S/C9H14O6/c1-6(10)13-4-9(15-8(3)12)5-14-7(2)11/h9H,4-5H2,1-3H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 1,2,3-Propanetriol triacetate | ChEBI | | 1,2,3-Propanetriyl triacetate | ChEBI | | 1,2,3-Triacetoxypropane | ChEBI | | 1,2,3-Triacetylglycerol | ChEBI | | 2-(Acetyloxy)-1-[(acetyloxy)methyl]ethyl acetate | ChEBI | | e 1518 | ChEBI | | e-1518 | ChEBI | | e1518 | ChEBI | | Enzactin | ChEBI | | Glycerin triacetate | ChEBI | | Glycerol triacetate | ChEBI | | Glyceryl triacetate | ChEBI | | Triacetina | ChEBI | | Triacetine | ChEBI | | Triacetinum | ChEBI | | Triacetyl glycerin | ChEBI | | Triacetyl glycerine | ChEBI | | Triacetylglycerol | ChEBI | | 1,2,3-Propanetriol triacetic acid | Generator | | 1,2,3-Propanetriyl triacetic acid | Generator | | 2-(Acetyloxy)-1-[(acetyloxy)methyl]ethyl acetic acid | Generator | | Glycerin triacetic acid | Generator | | Glycerol triacetic acid | Generator | | Glyceryl triacetic acid | Generator | | 1,2,3-Propanetriol triacetate, 9ci | HMDB | | 1,2,3-Propanetriol, 1,2,3-triacetate | HMDB | | 1,2,3-Propanetriol, triacetate | HMDB | | Acetic, 1,2,3-propanetriyl ester | HMDB | | Blekin | HMDB | | Enzacetin | HMDB | | Estol 1581 | HMDB | | Euzactin | HMDB | | FEMA 2007 | HMDB | | Fungacet | HMDB | | Fungacetin | HMDB | | Glycerol triacetate tributyrin | HMDB | | Glyped | HMDB | | Kesscoflex tra | HMDB | | Kodaflex triacetin | HMDB | | Motisil | HMDB | | Propane-1,2,3-triyl triacetate | HMDB | | Tri-acetin | HMDB | | Triacetin (1,2,3-propanetriol triacetate) | HMDB | | Triacetin (glycerol triacetate) | HMDB | | Triacetin, 8ci, ban, inn, usan | HMDB | | Triacetyl glycerol | HMDB | | Vanay | HMDB | | Triacetyl-glycerol | MeSH, HMDB |
|
|---|
| Chemical Formula | C9H14O6 |
|---|
| Average Molecular Weight | 218.2039 |
|---|
| Monoisotopic Molecular Weight | 218.07903818 |
|---|
| IUPAC Name | 1,3-bis(acetyloxy)propan-2-yl acetate |
|---|
| Traditional Name | triacetin |
|---|
| CAS Registry Number | 102-76-1 |
|---|
| SMILES | CC(=O)OCC(COC(C)=O)OC(C)=O |
|---|
| InChI Identifier | InChI=1S/C9H14O6/c1-6(10)13-4-9(15-8(3)12)5-14-7(2)11/h9H,4-5H2,1-3H3 |
|---|
| InChI Key | URAYPUMNDPQOKB-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerolipids |
|---|
| Sub Class | Triradylcglycerols |
|---|
| Direct Parent | Triacylglycerols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Triacyl-sn-glycerol
- Tricarboxylic acid or derivatives
- Carboxylic acid ester
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Liquid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | -78 °C | Not Available | | Boiling Point | 258.00 to 260.00 °C. @ 760.00 mm Hg | The Good Scents Company Information System | | Water Solubility | 58 mg/mL at 25 °C | Not Available | | LogP | 0.25 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.35 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.367 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.96 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 27.7 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1505.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 294.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 84.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 166.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 49.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 354.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 403.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 128.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 828.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 322.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1464.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 264.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 300.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 590.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 204.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 277.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Triacetin EI-B (Non-derivatized) | splash10-0zfs-3900000000-0e517995b789bd89015d | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Triacetin EI-B (Non-derivatized) | splash10-0007-7900000000-8dba8a82c4b9ea4fff14 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Triacetin EI-B (Non-derivatized) | splash10-0006-9100000000-4831fd0c53a09c852378 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Triacetin EI-B (Non-derivatized) | splash10-0zfs-3900000000-0e517995b789bd89015d | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Triacetin EI-B (Non-derivatized) | splash10-0007-7900000000-8dba8a82c4b9ea4fff14 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Triacetin EI-B (Non-derivatized) | splash10-0006-9100000000-4831fd0c53a09c852378 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Triacetin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 10V, Positive-QTOF | splash10-000i-0090000000-8a37824d0f2d133742dc | 2017-10-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 20V, Positive-QTOF | splash10-000i-0090000000-8a37824d0f2d133742dc | 2017-10-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 40V, Positive-QTOF | splash10-0aor-0970000000-2aef4d9a7612d8dafbfe | 2017-10-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 10V, Positive-QTOF | splash10-0006-0090000000-b38fc2a560bf20d37e0c | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 20V, Positive-QTOF | splash10-0006-0090000000-b38fc2a560bf20d37e0c | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 40V, Positive-QTOF | splash10-0006-0090000000-b38fc2a560bf20d37e0c | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 10V, Positive-QTOF | splash10-05mk-9710000000-f22af5cbf5889ccdd932 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 20V, Positive-QTOF | splash10-05mn-9400000000-7652606ae6706c4a9b17 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 40V, Positive-QTOF | splash10-000m-9100000000-e19f8f565c58ee733eea | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 10V, Negative-QTOF | splash10-0a4i-9410000000-298ddbbc7ca605058710 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 20V, Negative-QTOF | splash10-0a4i-9600000000-200967820af7347f4ccd | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 40V, Negative-QTOF | splash10-0a4i-9100000000-786d33c8b183715b60e2 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 10V, Positive-QTOF | splash10-000i-0090000000-47388b4e8c5a7aee1b2d | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 20V, Positive-QTOF | splash10-000i-0090000000-47388b4e8c5a7aee1b2d | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 40V, Positive-QTOF | splash10-0aor-1970000000-5d157472f8cf1a1268a6 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 10V, Positive-QTOF | splash10-004i-0090000000-8fc8dc18b58235d1fad0 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 20V, Positive-QTOF | splash10-004i-0090000000-8fc8dc18b58235d1fad0 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Triacetin 40V, Positive-QTOF | splash10-04mi-9990000000-873dc2c08186ded9c103 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-30 | Wishart Lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | |
|---|
| Biospecimen Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| Not Available |
|---|
| Abnormal Concentrations |
|---|
| Not Available |
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | None |
|---|
| Associated OMIM IDs | None |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB000751 |
|---|
| KNApSAcK ID | C00054037 |
|---|
| Chemspider ID | 13835706 |
|---|
| KEGG Compound ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Triacetin |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | 5541 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 9661 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| MarkerDB ID | Not Available |
|---|
| Good Scents ID | rw1027131 |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| Material Safety Data Sheet (MSDS) | Download (PDF) |
|---|
| General References | - Goembira F, Saka S: Optimization of biodiesel production by supercritical methyl acetate. Bioresour Technol. 2013 Mar;131:47-52. doi: 10.1016/j.biortech.2012.12.130. Epub 2012 Dec 27. [PubMed:23340101 ]
- Brault G, Shareck F, Hurtubise Y, Lepine F, Doucet N: Isolation and characterization of EstC, a new cold-active esterase from Streptomyces coelicolor A3(2). PLoS One. 2012;7(3):e32041. doi: 10.1371/journal.pone.0032041. Epub 2012 Mar 2. [PubMed:22396747 ]
- KARNS ME, PARKER R: The treatment of refractory fungus infections with fungacetin (triacetin). J Am Podiatry Assoc. 1959 Sep;49:411-2. [PubMed:14404545 ]
- Cheng M, Angkawidjaja C, Koga Y, Kanaya S: Requirement of lid2 for interfacial activation of a family I.3 lipase with unique two lid structures. FEBS J. 2012 Oct;279(19):3727-37. doi: 10.1111/j.1742-4658.2012.08734.x. Epub 2012 Aug 31. [PubMed:22863357 ]
- Malik B, Benaissa M: Determination of glucose concentration from near-infrared spectra using locally weighted partial least square regression. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:6169-71. doi: 10.1109/EMBC.2012.6347402. [PubMed:23367337 ]
- Sarkar B, Ravi V, Alexandridis P: Micellization of amphiphilic block copolymers in binary and ternary solvent mixtures. J Colloid Interface Sci. 2013 Jan 15;390(1):137-46. doi: 10.1016/j.jcis.2012.09.028. Epub 2012 Sep 26. [PubMed:23099248 ]
- Biedermann J, Owen AJ, Schloe KT, Gassner F, Sussmuth R: Interaction between poly-3-hydroxybutyrate-co-3-hydroxyvalerate and a denitrifying Pseudomonas strain. Can J Microbiol. 1997 Jun;43(6):561-8. [PubMed:9226875 ]
- Radomska-Soukharev A, Wojciechowska J: Microemulsions as potential ocular drug delivery systems: phase diagrams and physical properties depending on ingredients. Acta Pol Pharm. 2005 Nov-Dec;62(6):465-71. [PubMed:16583987 ]
- Laino T, Tuma C, Moor P, Martin E, Stolz S, Curioni A: Mechanisms of propylene glycol and triacetin pyrolysis. J Phys Chem A. 2012 May 10;116(18):4602-9. doi: 10.1021/jp300997d. Epub 2012 Apr 30. [PubMed:22512236 ]
- Inal O, Kilicarslan M, Ari N, Baykara T: In vitro and in vivo transdermal studies of atenolol using iontophoresis. Acta Pol Pharm. 2008 Jan-Feb;65(1):29-36. [PubMed:18536170 ]
- Liu H, Venkatraman SS: Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems. J Pharm Sci. 2012 May;101(5):1783-93. doi: 10.1002/jps.23065. Epub 2012 Feb 8. [PubMed:22318766 ]
- Gao Y, Li L, Zhang J, Shu W, Gao L: Simultaneous determination of triacetin, acetic ether, butyl acetate and amorolfine hydrochloride in amorolfine liniment by HPLC. Pak J Pharm Sci. 2012 Apr;25(2):389-94. [PubMed:22459467 ]
- Emara LH, Taha NF, Badr RM, Mursi NM: Development of an osmotic pump system for controlled delivery of diclofenac sodium. Drug Discov Ther. 2012 Oct;6(5):269-77. [PubMed:23229148 ]
- Camargo JA, Sapin A, Nouvel C, Daloz D, Leonard M, Bonneaux F, Six JL, Maincent P: Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization. Drug Dev Ind Pharm. 2013 Jan;39(1):146-55. doi: 10.3109/03639045.2012.660952. Epub 2012 Mar 8. [PubMed:22397675 ]
- Ziolek M, Burdzinski G, Douhal A: Long-living structures of photochromic salicylaldehyde azine: polarity and viscosity effects from nanoseconds to hours. Photochem Photobiol Sci. 2012 Aug;11(8):1389-400. doi: 10.1039/c2pp25081k. Epub 2012 Jun 22. [PubMed:22722683 ]
- CAHN MM, LEVY EJ: The use of triacetin (fungacetin) in the treatment of superficial dermatomycoses. Int Rec Med Gen Pract Clin. 1959 Jun;172(6):303-9. [PubMed:13664360 ]
- Vijayakumar KR, Gowda LR: Rice (Oryza sativa) lipase: molecular cloning, functional expression and substrate specificity. Protein Expr Purif. 2013 Mar;88(1):67-79. doi: 10.1016/j.pep.2012.11.011. Epub 2012 Nov 29. [PubMed:23202292 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Ghosh S, Strum JC, Bell RM: Lipid biochemistry: functions of glycerolipids and sphingolipids in cellular signaling. FASEB J. 1997 Jan;11(1):45-50. [PubMed:9034165 ]
- (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
- Linda T. Welson (2006). Triglycerides and Cholesterol Research. Nova Science Publishers Inc..
|
|---|